Prophylactic Treatment of Asymptomatic Patent Ductus Arteriosus in Premature Infants With Respiratory Distress Syndrome

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Southern medical journal (Birmingham, Ala. Print)

• Publication date

  1987-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007611-198706000-00010PMID 3296225
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patent ductus arteriosus in neonates with severe respiratory disease.

  1984cited by this paper
• EARLY CLOSURE OF PATENT DUCTUS ARTERIOSUS WITH INDOMETHACIN IN PRETERM INFANTS WITH IDIOPATHIC RESPIRATORY DISTRESS SYNDROME

  1983cited by this paper
• Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

  1983cited by this paper
• Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants.

  1982cited by this paper
• Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial.

  1981cited by this paper
• Specificity and accuracy of echocardiographic and clinical criteria for diagnosis of patent ductus arteriosus in fluid-restricted infants.

  1981cited by this paper
• Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus--a double-blind controlled study.

  1981cited by this paper
• Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants.

  1980cited by this paper
• The contribution of PDA in the neonate with severe RDS.

  1980cited by this paper
• Problem of patent ductus arteriosus in premature infants.

  1978cited by this paper
• New serial contrast technique for assessment of left to right shunting patent ductus arteriosus in the neonate.

  1978cited by this paper
• Twelve years' experience with bronchopulmonary dysplasia.

  1977cited by this paper

• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.

  2025cites this paper
• Comparison of Various Pharmacologic Agents in the Management of Hemodynamically Significant Patent Ductus Arteriosus in Preterm: A Network Meta-Analysis and Risk-Benefit Analysis

  2022cites this paper
• Factors Associated With Benefit of Treatment of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis

  2021cites this paper
• Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews

  2020cites this paper
• Does crossover treatment of control subjects invalidate results of randomized trials of patent ductus arteriosus treatment?

  2020cites this paper
• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.

  2020cites this paper
• Successful Closure of Patent Ductus Arteriosus by Late Pharmacologic Treatment in a Small Preterm Infant

  2019cites this paper
• Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial)

  2018cites this paper
• Pre-symptomatic targeted treatment of patent ductus arteriosus in preterm newborns: A systematic review and meta-analysis

  2018cites this paper
• Reflections of the changes in patent ductus arteriosus management during the last 10 years

  2016cites this paper
• Preterm patent ductus arteriosus: A continuing conundrum for the neonatologist?

  2015cites this paper
• Patent Ductus Arteriosus in Preterm Infants: Do We Have the Right Answers?

  2013cites this paper
• Systematic review and network meta-analysis of intravenous ibuprofen vs. intravenous indomethacin vs. placebo in the management of clinically and/or echocardiographically important patent ductus arteriosus in preterm infants at greater than 24 hours of life

  2012cites this paper
• Patent Ductus Arteriosus and the Lung

  2012cites this paper
• Patent Ductus Arteriosus in Premature Neonates

  2012cites this paper
• Chapter 8 – Patent Ductus Arteriosus and the Lung: Acute Effects and Long-Term Consequences

  2012cites this paper
• Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants

  2010cites this paper
• Cochrane Review: Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants

  2010cites this paper
• Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.

  2010cites this paper
• Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?

  2010cites this paper
• Primer consenso clínico de SIBEN: enfoque diagnóstico y terapéutico del ductus arterioso permeable en recién nacidos pretérmino

  2008cites this paper
• SIBEN's First Clinical Consensus: Diagnostic and Therapeutic Approach to the Patent Ductus Arteriosus in Preterm Infants

  2008cites this paper
• Patent Ductus Arteriosus and Respiratory Outcome in Premature Infants

  2005cites this paper
• Indomethacin for asymptomatic patent ductus arteriosus in preterm infants.

  2003cites this paper
• The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials.

  2001cites this paper
• Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome.

  2001cites this paper
• Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants.

  2000cites this paper
• Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies.

  1996cites this paper